Abstract:Abstract-The microvascular pulmonary endothelium barrier is critical in preventing interstitial fluid overflow and deterioration in gas diffusion. The role of endothelium in transporting small solutes in pathological conditions, such as congestive heart failure (CHF), has not been studied. Monitoring of pulmonary gas transfer during saline infusion in CHF was used to probe this issue. Carbon monoxide diffusion (DL CO ), its membrane diffusion (D M ) and capillary blood volume (V C ) subcomponents, and mean rig… Show more
“…In a study performed in post-MI patients with normal LV systolic function, an infusion of ~800 mL of saline reduced Dm by 13% 49 . In patients with mild to severe HF, a 150 ml infusion of saline produced a significant Dm reduction equivalent to 750 ml saline, whereas a 750 mL infusion of isotonic glucose solution did not decrease DLco and Dm 50 . None of these infusions caused changes in right atrial or pulmonary wedge pressures.…”
Cardiac dysfunction of both systolic and diastolic origin leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolarcapillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitations and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.
“…In a study performed in post-MI patients with normal LV systolic function, an infusion of ~800 mL of saline reduced Dm by 13% 49 . In patients with mild to severe HF, a 150 ml infusion of saline produced a significant Dm reduction equivalent to 750 ml saline, whereas a 750 mL infusion of isotonic glucose solution did not decrease DLco and Dm 50 . None of these infusions caused changes in right atrial or pulmonary wedge pressures.…”
Cardiac dysfunction of both systolic and diastolic origin leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolarcapillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitations and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.
“…Indeed, in heart failure patients, a low SaO 2 at rest or after alveolar-capillary membrane challenge such as fluid overload or exercise is an unusual event [71][72][73]. In healthy subjects, rapid infusion of saline is associated to a slight reduction of spirometric parameters but an unchanged DLCO and SaO 2 [74,75].…”
“…The DLCO reduction is greater when a β1-β2 blocker (carvedilol) is used compared with a β1 selective blocker (bisoprolol) (figure 5) [74]. In contrast, heart failure patients show a decrease in DLCO with even a small amount of saline infusion or physical exercise [71][72][73], suggesting that the lung fluid balance is in a critical condition. Indeed, in heart failure the alveolar-capillary membrane undergoes an extensive remodelling process.…”
Exertional dyspnoea is among the dominant symptoms in patients with chronic heart failure and progresses relentlessly as the disease advances, leading to reduced ability to function and engage in activities of daily living. Effective management of this disabling symptom awaits a better understanding of its underlying physiology.Cardiovascular factors are believed to play a major role in dyspnoea in heart failure patients. However, despite pharmacological interventions, such as vasodilators or inotropes that improve central haemodynamics, patients with heart failure still complain of exertional dyspnoea. Clearly, dyspnoea is not determined by cardiac factors alone, but likely depends on complex, integrated cardio-pulmonary interactions.A growing body of evidence suggests that excessively increased ventilatory demand and abnormal "restrictive" constraints on tidal volume expansion with development of critical mechanical limitation of ventilation, contribute to exertional dyspnoea in heart failure. This article will offer new insights into the pathophysiological mechanisms of exertional dyspnoea in patients with chronic heart failure by exploring the potential role of the various constituents of the physiological response to exercise and particularly the role of abnormal ventilatory and respiratory mechanics responses to exercise in the perception of dyspnoea in patients with heart failure. @ERSpublications In heart failure, respiratory and peripheral factors play a significant role in exertional dyspnoea development
“…Notably, Guazzi et al also showed that impediment of gas transfer with salt infusion in CHF, despite an increase in capillary blood volume and no variations in pulmonary hydrostatic forces, indicates an upregulation in sodium transport from blood to interstitium with interstitial edema. Redistribution of blood from the lungs, facilitating interstitial fluid reabsorption, or sodium uptake from the alveolar lumen by the sodium-glucose cotransport system might underlie the improved alveolar-capillary conductance with glucose [11,12]. In patients with chronic CHF, there is an increase in the number of alveolar type II cells [13].…”
Section: Histological Changes In Lungs With Heart Failurementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.